{'fraction_non_alphanumeric': 0.020588235294117647, 'fraction_numerical': 0.0014705882352941176, 'mean_word_length': 5.364485981308412, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Continued therapeutic improvements for OIs.


 Several presentations at the Vancouver International Conference on AIDS reported continued improvements in the treatment of opportunistic infections. New and ongoing studies for MAC were reported, including one that alerted clinicians to the dangers of using high-dose clarithromycin for therapy. PCP, for which there are effective prophylactic therapies, continues to be the most common of the opportunistic infections, and studies show low survival rates for patients who require ICU stays of longer than 2 weeks. Evidence continues to show that Kaposi's sarcoma (KS) may be a variation of herpes, another opportunistic infection.
